![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RL Papke and SF Heinemann
Molecular Neurobiology Laboratory, Salk Institute, San Diego, California 92186-5800.
As previously reported by Luetje and Patrick [J. Neurosci. 11:837-845 (1991)], the nicotine-like alkaloid cytisine is relatively ineffective in evoking current responses from nicotinic receptors containing the beta 2 subunit. In our experiments, the responses of alpha 4 beta 2- and alpha 3 beta 2-injected oocytes to the application of 1 mM cytisine were only 14.7 +/- 4% and 2.5 +/- 0.8% of the responses to 1 mM acetylcholine (ACh), respectively. Concentration-response relationships for ACh were examined in the presence and absence of cytisine. Although cytisine was relatively ineffective in stimulating current, the coapplication of cytisine and ACh reduced the responses to ACh. For alpha 4 beta 2 receptors, 3 microM cytisine shifted the dose-response curve for ACh to the right, resulting in a 60-fold increase in the apparent EC50 for ACh. For alpha 3 beta 2 receptors, 30 microM cytisine shifted the apparent EC50 for ACh from approximately 150 microM to 1 mM. Although the efficacy of cytisine for alpha 3 beta 2 receptors was very low, cytisine could effectively inhibit the responses of these receptors, with an IC50 of approximately 10 microM. The efficacy of cytisine for alpha 4 beta 2 receptors was greater than that for alpha 3 beta 2 receptors, and it was possible to evaluate the partial agonist properties of cytisine for these receptors. Although the EC50 of cytisine for stimulating current through alpha 4 beta 2 receptors was about 1 microM, concentrations of cytisine as low as 20 nM were able to inhibit 50% of the response to 1 microM ACh. The inhibitory effects of cytisine were reversible over a period of 5 min. Our analysis suggests that cytisine is a true partial agonist for beta 2-containing ACh receptors and as such can inhibit the response of these receptors to ACh through a competitive mechanism. In the case of alpha 4 beta 2 receptors cytisine binds with high apparent affinity and low efficacy to a site shared with ACh, and for alpha 3 beta 2 receptors both the apparent affinity and efficacy of cytisine are relatively low.
This article has been cited by other articles:
|
|
 |
|
  M. De Biasi and R. Salas Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal Experimental Biology and Medicine, August 1, 2008; 233(8): 917 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Salminen, J. A. Drapeau, J. M. McIntosh, A. C. Collins, M. J. Marks, and S. R. Grady Pharmacology of {alpha}-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice Mol. Pharmacol., June 1, 2007; 71(6): 1563 - 1571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Azam and J. M. McIntosh Characterization of Nicotinic Acetylcholine Receptors That Modulate Nicotine-Evoked [3H]Norepinephrine Release from Mouse Hippocampal Synaptosomes Mol. Pharmacol., September 1, 2006; 70(3): 967 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Mihalak, F. I. Carroll, and C. W. Luetje Varenicline Is a Partial Agonist at {alpha}4beta2 and a Full Agonist at {alpha}7 Neuronal Nicotinic Receptors Mol. Pharmacol., September 1, 2006; 70(3): 801 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Etter Cytisine for Smoking Cessation: A Literature Review and a Meta-analysis. Arch Intern Med, August 14, 2006; 166(15): 1553 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gonzales, S. I. Rennard, M. Nides, C. Oncken, S. Azoulay, C. B. Billing, E. J. Watsky, J. Gong, K. E. Williams, K. R. Reeves, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA, July 5, 2006; 296(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of {alpha}4beta2 and {alpha}3beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., July 1, 2006; 70(1): 227 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Criado, J. Mulet, J. A. Bernal, S. Gerber, S. Sala, and F. Sala Mutations of a Conserved Lysine Residue in the N-Terminal Domain of {alpha}7 Nicotinic Receptors Affect Gating and Binding of Nicotinic Agonists Mol. Pharmacol., December 1, 2005; 68(6): 1669 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Placzek, F. Grassi, E. M Meyer, and R. L. Papke An {alpha}7 Nicotinic Acetylcholine Receptor Gain-of-Function Mutant That Retains Pharmacological Fidelity Mol. Pharmacol., December 1, 2005; 68(6): 1863 - 1876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Zhu, R. R. Stewart, J. M. McIntosh, and F. F. Weight Activation of Nicotinic Acetylcholine Receptors Increases the Frequency of Spontaneous GABAergic IPSCs in Rat Basolateral Amygdala Neurons J Neurophysiol, November 1, 2005; 94(5): 3081 - 3091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Rau, R. D. Johnson, and B. Y. Cooper Nicotinic AChR in Subclassified Capsaicin-Sensitive and -Insensitive Nociceptors of the Rat DRG J Neurophysiol, March 1, 2005; 93(3): 1358 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-J. Cao, C. S. Surowy, and P. S. Puttfarcken Nicotinic Acetylcholine Receptor-Mediated [3H]Dopamine Release from Hippocampus J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1298 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Hernandez, S. Vicini, Y. Xiao, M. I. Davila-Garcia, R. P. Yasuda, B. B. Wolfe, and K. J. Kellar The Nicotinic Receptor in the Rat Pineal Gland Is an {alpha}3{beta}4 Subtype Mol. Pharmacol., October 1, 2004; 66(4): 978 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhou, M. E. Nelson, A. Kuryatov, C. Choi, J. Cooper, and J. Lindstrom Human {alpha}4{beta}2 Acetylcholine Receptors Formed from Linked Subunits J. Neurosci., October 8, 2003; 23(27): 9004 - 9015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Avila, M. I. Davila-Garcia, V. S. Ascarrunz, Y. Xiao, and K. J. Kellar Differential Regulation of Nicotinic Acetylcholine Receptors in PC12 Cells by Nicotine and Nerve Growth Factor Mol. Pharmacol., October 1, 2003; 64(4): 974 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alkondon, E. F.R. Pereira, and E. X. Albuquerque NMDA and AMPA Receptors Contribute to the Nicotinic Cholinergic Excitation of CA1 Interneurons in the Rat Hippocampus J Neurophysiol, September 1, 2003; 90(3): 1613 - 1625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Nelson, A. Kuryatov, C. H. Choi, Y. Zhou, and J. Lindstrom Alternate Stoichiometries of alpha 4beta 2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., February 1, 2003; 63(2): 332 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Khan, E. Singletary, A. Alemayehu, S. Stanislaus, M. P. Printz, T. L. Yaksh, and P. Taylor Nicotinic receptor gene cluster on rat chromosome 8 in nociceptive and blood pressure hyperresponsiveness Physiol Genomics, October 29, 2002; 11(2): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ji, T. Tosaka, B. H. Whitfield, A. N. Katchman, A. Kandil, B. C. Knollmann, and S. N. Ebert Differential Rate Responses to Nicotine in Rat Heart: Evidence for Two Classes of Nicotinic Receptors J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rush, A. Kuryatov, M. E. Nelson, and J. Lindstrom First and Second Transmembrane Segments of alpha 3, alpha 4, beta 2, and beta 4 Nicotinic Acetylcholine Receptor Subunits Influence the Efficacy and Potency of Nicotine Mol. Pharmacol., June 1, 2002; 61(6): 1416 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Meyer, L. C. Gahring, and S. W. Rogers Nicotine Preconditioning Antagonizes Activity-dependent Caspase Proteolysis of a Glutamate Receptor J. Biol. Chem., March 22, 2002; 277(13): 10869 - 10875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Genzen, W. Van Cleve, and D. S. McGehee Dorsal Root Ganglion Neurons Express Multiple Nicotinic Acetylcholine Receptor Subtypes J Neurophysiol, October 1, 2001; 86(4): 1773 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Meyer, Y. Xiao, and K. J. Kellar Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Schneider and J. J. Galligan Presynaptic nicotinic acetylcholine receptors in the myenteric plexus of guinea pig intestine Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G528 - G535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lena, A. de Kerchove d'Exaerde, M. Cordero-Erausquin, N. Le Novere, M. del Mar Arroyo-Jimenez, and J.-P. Changeux Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons PNAS, October 12, 1999; 96(21): 12126 - 12131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Galligan Nerve Terminal Nicotinic Cholinergic Receptors on Excitatory Motoneurons in the Myenteric Plexus of Guinea Pig Intestine J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 92 - 98. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Levandoski, Y. Lin, L. Moise, J. T. McLaughlin, E. Cooper, and E. Hawrot Chimeric Analysis of a Neuronal Nicotinic Acetylcholine Receptor Reveals Amino Acids Conferring Sensitivity to alpha -Bungarotoxin J. Biol. Chem., September 10, 1999; 274(37): 26113 - 26119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sabey, K. Paradiso, J. Zhang, and J. H. Steinbach Ligand Binding and Activation of Rat Nicotinic alpha 4beta 2 Receptors Stably Expressed in HEK293 Cells Mol. Pharmacol., January 1, 1999; 55(1): 58 - 66. [Abstract] [Full Text]
|
|
|
|
|
|
R. Anand, M. E. Nelson, V. Gerzanich, G. B. Wells, and J. Lindstrom Determinants of Channel Gating Located in the N-Terminal Extracellular Domain of Nicotinic alpha 7 Receptor J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 469 - 479. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Xiao, E. L. Meyer, J. M. Thompson, A. Surin, J. Wroblewski, and K. J. Kellar Rat alpha 3/beta 4 Subtype of Neuronal Nicotinic Acetylcholine Receptor Stably Expressed in a Transfected Cell Line: Pharmacology of Ligand Binding and Function Mol. Pharmacol., August 1, 1998; 54(2): 322 - 333. [Abstract] [Full Text]
|
|
|
|
|
|
V. Gerzanich, F. Wang, A. Kuryatov, and J. Lindstrom alpha 5 Subunit Alters Desensitization, Pharmacology, Ca++ Permeability and Ca++ Modulation of Human Neuronal alpha 3 Nicotinic Receptors J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 311 - 320. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bencherif, J. D. Schmitt, B. S. Bhatti, P. Crooks, W. S. Caldwell, M. E. Lovette, K. Fowler, L. Reeves, and P. M. Lippiello The Heterocyclic Substituted Pyridine Derivative (±)-2-(-3-pyridinyl)-1-Azabicyclo[2.2.2]octane (RJR-2429): A Selective Ligand at Nicotinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 886 - 894. [Abstract] [Full Text]
|
|
|
|
|
|
M. I. Damaj, M. Fei-Yin, M. Dukat, W. Glassco, R. A. Glennon, and B. R. Martin Antinociceptive Responses to Nicotinic Acetylcholine Receptor Ligands after Systemic and Intrathecal Administration in Mice J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1058 - 1065. [Abstract] [Full Text]
|
|
|
|
|
|
W. R. Kem, V. M. Mahnir, R. L. Papke, and C. J. Lingle Anabaseine Is a Potent Agonist on Muscle and Neuronal Alpha-Bungarotoxin-Sensitive Nicotinic Receptors J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 979 - 992. [Abstract] [Full Text]
|
|
|
|
|
|
J. P. Sullivan, D. Donnelly-Roberts, C. A. Briggs, D. J. Anderson, M. Gopalakrishnan, I. C. Xue, M. Piattoni-Kaplan, E. Molinari, J. E. Campbell, D. G. Mckenna, et al. ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 235 - 246. [Abstract] [Full Text]
|
|
|
|
|
|
B. W. Wenger, D. L. Bryant, R. T. Boyd, and D. B. McKay Evidence for Spare Nicotinic Acetylcholine Receptors and a beta 4 Subunit in Bovine Adrenal Chromaffin Cells: Studies using Bromoacetylcholine, Epibatidine, Cytisine and mAb35 J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 905 - 913. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
